135323-95-4 Usage
Description
2-CHLORO-4-(MORPHOLIN-4-YLCARBONYL)QUINOLINE is a chlorinated quinoline derivative with the molecular formula C15H12ClN3O2, featuring a morpholine-4-ylcarbonyl group. This chemical compound possesses potential biological activity and is being explored for its applications in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
2-CHLORO-4-(MORPHOLIN-4-YLCARBONYL)QUINOLINE is used as a chemical intermediate for the development of new drugs due to its potential antibacterial properties. It is being studied for its ability to combat bacterial infections, which could lead to the creation of novel antibiotics.
Used in Organic Synthesis:
In the field of organic synthesis, 2-CHLORO-4-(MORPHOLIN-4-YLCARBONYL)QUINOLINE is used as a building block for the synthesis of more complex organic compounds. Its unique structure allows it to be a valuable component in the creation of various pharmaceutical agents and other organic molecules.
Used in Chemical Research:
2-CHLORO-4-(MORPHOLIN-4-YLCARBONYL)QUINOLINE is also utilized in chemical research for studying the properties and reactions of chlorinated quinoline derivatives. This research can contribute to the understanding of structure-activity relationships and the development of new chemical methodologies.
Check Digit Verification of cas no
The CAS Registry Mumber 135323-95-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,3,2 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 135323-95:
(8*1)+(7*3)+(6*5)+(5*3)+(4*2)+(3*3)+(2*9)+(1*5)=114
114 % 10 = 4
So 135323-95-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H13ClN2O2/c15-13-9-11(10-3-1-2-4-12(10)16-13)14(18)17-5-7-19-8-6-17/h1-4,9H,5-8H2
135323-95-4Relevant articles and documents
Synthesis and anti-tuberculosis activity of 2,4-disubstituted quinolines
Nayyar, Amit,Jain, Rahul
, p. 117 - 128 (2008/09/20)
Synthesis and anti-tuberculosis activity of a new series of 2,4-disubstituted quinolines have been reported. The most promising compounds have been found to exhibit 99% inhibition at 6.25 ng/mL against drug-sensitive M. tuberculosis H37Rv strain and >90% inhibition at 12.5 ng/mL against isoniazid resistant TB strain.
